CytomX Therapeutics (CTMX) Revenue (2014 - 2026)
CytomX Therapeutics' Revenue came in at $1.42 million for Q2 2026, down 92.4% from $18.66 million a year earlier and down 86.2% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Revenue (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CytomX Therapeutics reported Revenue of $18.3 million, down 87.0% year-over-year; for FY2025, it came in at $76.2 million, down 44.8% from FY2024.
- Revenue carries a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
- Going back by year, Revenue was $138.1 million in FY2024 (+36.4%), $101.21 million in FY2023 (+90.4%), $53.16 million in FY2022 (+42.5%) and $37.31 million in FY2021 (-45.5%).
- The five-year range for quarterly Revenue is $663,000 (Q4 2025) to $50.92 million (Q1 2025).
- Year-over-year, Revenue has declined for five consecutive quarters, with an average decline of 35.7% over the last eight quarters.
- The fastest year-over-year change in Revenue over five years came in Q1 2023 (growth of 159.9%), and the weakest in Q4 2025 (a decline of 98.3%).
- Business Quant data shows CTMX's Revenue at $10.26 million (Q1 2026), $663,000 (Q4 2025) and $5.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | 10.26 Mn |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 18.66 Mn |
| Mar 31, 2025 | 50.92 Mn |
| Dec 31, 2024 | 38.09 Mn |
| Sep 30, 2024 | 33.43 Mn |
| Jun 30, 2024 | 25.12 Mn |
| Mar 31, 2024 | 41.46 Mn |
| Dec 31, 2023 | 26.61 Mn |
| Sep 30, 2023 | 26.38 Mn |
| Jun 30, 2023 | 24.72 Mn |
| Mar 31, 2023 | 23.50 Mn |
| Dec 31, 2022 | 20.12 Mn |
| Sep 30, 2022 | 11.15 Mn |
| Jun 30, 2022 | 12.85 Mn |
| Mar 31, 2022 | 9.04 Mn |
| Dec 31, 2021 | 11.13 Mn |
| Sep 30, 2021 | 9.19 Mn |
API Access
CytomX Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();